Edith Graef McGeer - Society for Neuroscience
Edith Graef McGeer - Society for Neuroscience
Edith Graef McGeer - Society for Neuroscience
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
346 Patrick L. <strong>McGeer</strong> and <strong>Edith</strong> <strong>Graef</strong><strong>McGeer</strong><br />
Mapping of GABA Neurons by GABA Transaminase<br />
Eugene Roberts and coworkers eliminated any last doubts about GABA<br />
being a neurotransmitter when they identified neurons and nerve endings<br />
containing its synthetic enzyme glutamic acid decarboxylase (GAD).<br />
The immunohistochemical methodology they employed was sensitive<br />
enough to reveal certain groups of neurons, but it was not a practical way<br />
to do a complete mapping of the brain. We wished to develop a simple<br />
method <strong>for</strong> doing so and thus developed the pharmacohistochemical<br />
method <strong>for</strong> GABA-T GABA-T, being a transaminase, would react with<br />
<strong>for</strong>mazan dyes to yield visible products, but its localization was not<br />
restricted to neurons. Astrocytes, being responsible <strong>for</strong> picking up<br />
neuronally released GABA, contained large quantities. Steve Vincent and<br />
Hiro Kimura overcame this problem by applying a strategy previously<br />
developed by Larry Butcher <strong>for</strong> acetylcholinesterase. An irreversible<br />
GABA-T inhibitor was given to a rat in vivo. Sacrifice was then timed so<br />
that recovery of GABA-T would occur in neurons but not in the less active<br />
glial cells. Ethanolamine-0-sulfate was used as the specific and irreversible<br />
inhibitor of GABA-T Toshi Nagai and Masa Araki, two of Hiro<br />
Kimura's successors from Japan, then applied the technique to the first<br />
complete mapping of GABA neurons, i.e., those containing high levels of<br />
GABA-T. Many of the neurons were types already known to be interneurons,<br />
but others were associated with key pathways, particularly in the<br />
basal ganglia.<br />
Glutamate Pathways<br />
Physiologists had long been aware that glutamate and aspartate are<br />
strongly excitatory, and it was suspected that they played major roles as<br />
excitatory neurotransmitters in brain. However, proving this suspicion<br />
and localizing them to specific pathways was difficult because they are<br />
amino acids with numerous nontransmitter roles. Glutamate, <strong>for</strong> example,<br />
is incorporated into proteins and peptides, is involved in fatty acid synthesis,<br />
and contributes to the regulation of ammonia and the control of<br />
osmotic or anionic balance. It serves as a precursor <strong>for</strong> GABA and <strong>for</strong> various<br />
Krebs cycle intermediates, and it is a constituent of important cofactors<br />
such as glutathione and folic acid. How then could neurotransmitter<br />
glutamate be distinguished? Our first attempt was to use high-affinity,<br />
sodium-dependent uptake in synaptosomal fractions from key areas as a<br />
possible measure of glutamatergic nerve endings. Spencer had suggested<br />
that the massive corticostriatal path used glutamate on the grounds that<br />
excitation of striatal cells by stimulation of this pathway was antagonized<br />
by diethyl glutamate. Working with Uschi Scherer and Vijendra Singh,<br />
we found that surgical lesions of the corticostriatal path in rats caused<br />
a significant 40% reduction in glutamate uptake in the synaptosomal